Status:
COMPLETED
Project Persist: mHealth for Cancer Survivorship
Lead Sponsor:
University of Oklahoma
Conditions:
Symptom Management
Reduce Treatment Non-adherence
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Many studies have shown that anxiety and depression are associated with reduced treatment adherence and poor treatment outcomes among patients undergoing cancer treatments. Given the negative conseque...
Detailed Description
A total of 60 individuals will be recruited from the OU Medicine Radiation Oncology Clinic (radiation clinic). All participants will be adults who are beginning radiation treatments for breast, gyneco...
Eligibility Criteria
Inclusion
- Eligible participants include adults 18+ who are:
- community dwelling
- diagnosed with a primary breast or gynecological or head and neck cancer
- ordered to receive radiation treatments during a minimum of 5-6 consecutive weeks
- able to read at the 7th grade level, speak, and write English.
- scheduled for 5-6 weeks of radiation therapy
Exclusion
- radiation treatment with primary palliative intent
- radiation treatment protocol occurring in a time period of less than 6 weeks
- severe visual impairment that limits mobile technology use (e.g, partial or full blindness)
- history of dementia or other major neurocognitive disorder. There are no early termination criteria; however, individuals can elect to stop participation in mobile monitoring at any time.
Key Trial Info
Start Date :
July 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 19 2023
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04126642
Start Date
July 27 2020
End Date
October 19 2023
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73104